NOT KNOWN FACTUAL STATEMENTS ABOUT PMTA 0 11

What's more, it addresses the FDA’s communications Using the applicant, the retention of data that support the SE report, confidentiality of an SE report, how an applicant can amend or withdraw an SE report, how an applicant may possibly transfer possession of an SE report back to a completely new applicant and electronic submission in the SE rep